ESR1 and neoplasm: Age < 45 years old, more than 25% positive node ratio, medial tumor location, estrogen receptor (ER) negative status and lymphovascular invasion (LVI) all are independently significant factors of LR.18–20 Multidisciplinary therapy, including PMRT, should be considered to apply in this subgroup for optimal local control and possible survival benefit.